iNova Pharmaceuticals (Australia) - Nyal Paracetamol 500mg

Therapeutic Goods Act 1989

Approval under section 42DF for use of restricted representations by iNova Pharmaceuticals (Australia) Pty Ltd

I, Elizabeth Butt, as a delegate of the Secretary to the Department of Health, on receipt of an application from iNova Pharmaceuticals (Australia) Pty Ltd, have approved under section 42DF of the Therapeutic Goods Act 1989 (the Act) the restricted representations described in paragraph (A) below for use in consumer advertising of the products identified in paragraph (B):

1.  
   • Representations to the effect that the Medicines can be used for the temporary relief of pain associated with arthritis, osteoarthritis, fibrositis, neuralgia, and rheumatic pain (where referenced individually or collectively)
2.  
   • NYAL PARACETAMOL, paracetamol 500mg mg tablet blister pack (AUST R 350070)
   • NYAL PARACETAMOL, paracetamol 500mg capsule blister pack (AUST R 350254), (the Medicines).

Dated this 23rd day of July 2021

Signed electronically

Elizabeth Butt
Delegate of the Secretary to the Department of Health
Advertising and Compliance Education and Policy Section
Regulatory Compliance Branch